Several cell-intrinsic effectors drive type I interferon-mediated restriction of HIV-1 in primary CD4+ T cells
Open Access
- 23 May 2023
- journal article
- research article
- Published by Elsevier in Cell Reports
- Vol. 42 (6) , 112556
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- National Institute on Drug Abuse (DP1 DA039543)
- National Institute of General Medical Sciences (T32 GM007270)
- National Institute of Allergy and Infectious Diseases (F31 AI165168)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01 HD103571)
- National Institutes of Health
This publication has 87 references indexed in Scilit:
- Host Gene Expression Changes Correlating With Anti–HIV-1 Effects in Human Subjects After Treatment With Peginterferon Alfa-2aThe Journal of Infectious Diseases, 2012
- Global landscape of HIV–human protein complexesNature, 2011
- A diverse range of gene products are effectors of the type I interferon antiviral responseNature, 2011
- Interferon-Stimulated Gene 15 and the Protein ISGylation SystemJournal of Interferon & Cytokine Research, 2011
- Safety, Tolerability, and Mechanisms of Antiretroviral Activity of Pegylated Interferon Alfa‐2a in HIV‐1–Monoinfected Participants: A Phase II Clinical TrialThe Journal of Infectious Diseases, 2010
- Signal peptide peptidase (SPP) assembles with substrates and misfolded membrane proteins into distinct oligomeric complexesBiochemical Journal, 2010
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression dataBioinformatics, 2009
- Cellular cofactors affecting hepatitis C virus infection and replicationProceedings of the National Academy of Sciences, 2007
- The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeysNature, 2004
- Intramembrane proteolysis promotes trafficking of hepatitis C virus core protein to lipid dropletsThe EMBO Journal, 2002